Inscobee Inc. - 12 May 2025 SCHEDULE 13D Report for Apimeds Pharmaceuticals US, Inc. Common Stock

Filing Manager
Inscobee Inc.
Reporting Manager
Apimeds Inc.
Security
Apimeds Pharmaceuticals US, Inc. Common Stock
Shares outstanding
11,577,066 shares
Disclosed Ownership
4,387,708 shares
Ownership
37.9%
Form type
SCHEDULE 13D
Filing time
19 May 2025, 21:29:56 UTC
Date of event
12 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Inscobee Inc. 17.5% 2,028,657 2,028,657 0 /s/ Jakap Koo Jakap Koo, Chief Executive Officer 0002057997
Apimeds Inc. 37.9% 4,387,708 4,387,708 0 /s/ Jakap Koo Jakap Koo, Chief Executive Officer